283 related articles for article (PubMed ID: 17284715)
1. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study.
Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister A; Radford JA; Rohatiner AZ; Linch DC
J Natl Cancer Inst; 2007 Feb; 99(3):206-14. PubMed ID: 17284715
[TBL] [Abstract][Full Text] [Related]
2. An affair of the heart.
Boice JD
J Natl Cancer Inst; 2007 Feb; 99(3):186-7. PubMed ID: 17284708
[No Abstract] [Full Text] [Related]
3. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
Boekel NB; Schaapveld M; Gietema JA; Russell NS; Poortmans P; Theuws JC; Schinagl DA; Rietveld DH; Versteegh MI; Visser O; Rutgers EJ; Aleman BM; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1061-72. PubMed ID: 27026313
[TBL] [Abstract][Full Text] [Related]
4. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
6. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.
Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister TA; Radford JA; Rohatiner AZ; Linch DC
J Clin Oncol; 2011 Nov; 29(31):4096-104. PubMed ID: 21969511
[TBL] [Abstract][Full Text] [Related]
7. [Cardiac pathology in patients after therapy for Hodgkin's lymphoma].
Danilenko AA; Shakhtarina SV
Vopr Onkol; 2011; 57(1):119-25. PubMed ID: 21598720
[No Abstract] [Full Text] [Related]
8. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
[TBL] [Abstract][Full Text] [Related]
10. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
[TBL] [Abstract][Full Text] [Related]
12. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
13. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
[TBL] [Abstract][Full Text] [Related]
14. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
15. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
Eich HT; Diehl V; Görgen H; Pabst T; Markova J; Debus J; Ho A; Dörken B; Rank A; Grosu AL; Wiegel T; Karstens JH; Greil R; Willich N; Schmidberger H; Döhner H; Borchmann P; Müller-Hermelink HK; Müller RP; Engert A
J Clin Oncol; 2010 Sep; 28(27):4199-206. PubMed ID: 20713848
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
17. Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience.
Wahner-Roedler DL; Nelson DF; Croghan IT; Achenbach SJ; Crowson CS; Hartmann LC; O'Fallon WM
Mayo Clin Proc; 2003 Jun; 78(6):708-15. PubMed ID: 12934780
[TBL] [Abstract][Full Text] [Related]
18. [Our experiences in treating patients with Hodgkin disease in the last decade].
Simon Z; Keresztes K; Miltényi Z; Ress Z; Váróczy L; Vadász G; Gergely L; Illés A
Orv Hetil; 2007 Apr; 148(15):675-82. PubMed ID: 17416575
[TBL] [Abstract][Full Text] [Related]
19. Noncancer causes of death in survivors of testicular cancer.
Fosså SD; Gilbert E; Dores GM; Chen J; McGlynn KA; Schonfeld S; Storm H; Hall P; Holowaty E; Andersen A; Joensuu H; Andersson M; Kaijser M; Gospodarowicz M; Cohen R; Pukkala E; Travis LB
J Natl Cancer Inst; 2007 Apr; 99(7):533-44. PubMed ID: 17405998
[TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
